Explay

Explay is a French biotechnology company specializing in the development of plant-derived extracellular vesicles (PDEVs) for therapeutic delivery. The company utilizes a proprietary platform to extract and engineer these natural nanovesicles, which serve as robust carriers for various payloads such as mRNA, proteins, and small molecules. By leveraging plant-based sources, Explay offers a scalable and cost-effective alternative to mammalian exosomes and synthetic lipid nanoparticles. Their technology is designed to minimize immunogenicity while enhancing the stability and targeted delivery of therapeutic agents. The company's primary focus areas include oncology and inflammatory diseases, where precise delivery is critical for efficacy. As a spin-off from the CNRS and Université Paris Cité, Explay is built on extensive research into the biophysical properties of extracellular vesicles.